Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
509 News Releases found
Newly Engineered Monoclonal Antibody Shows Promise, Moves toward Clinical Testing

Memorial Sloan Kettering and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
Media Advisory
Pictured: Jedd Wolchok and Alexander Rudensky
Memorial Sloan Kettering Cancer Center Shares $540 Million in New Funding From Ludwig Cancer Research

Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research.
Pictured: Ross Levine
Foundation Medicine Launches FoundationOne™ Heme, Developed in Collaboration with Memorial Sloan Kettering Cancer Center

FoundationOne Heme was developed using technology, methods and computational algorithms developed by Foundation Medicine, combined with Memorial Sloan Kettering’s deep and vast expertise in clinical and laboratory research into hematologic malignancies.
Pictured: Michael Foley
Accomplished Scientist and Entrepreneur Selected to Lead Tri-Institutional Therapeutics Discovery Institute

Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc., a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.
Pictured: Richard Barakat
New Position Created to Oversee Memorial Sloan Kettering’s Regional Care Network and Alliance

Memorial Sloan Kettering Cancer Center has announced the appointment of surgical oncologist Richard Barakat to the new position of Deputy Physician-in-Chief for the Memorial Sloan Kettering Regional Care Network and Alliance.
Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda

Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. and have partnered with Takeda Pharmaceutical Company, Ltd.
Pictured: Levi A. Garraway; Duojia (DJ) Pan; and Simon J. Boulton
Three Young Investigators Named Winners of Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research.
Memorial Sloan Kettering Leads Initiative to Reduce Health Disparities in U.S. South Asian Population

Memorial Sloan Kettering Cancer Center is leading an innovative initiative to reduce cancer and cardiovascular health disparities in South Asian immigrant communities in the United States.
""
Unprecedented Cancer Alliance Announced

Memorial Sloan Kettering Cancer Center today launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare, a multi-hospital health care system in Connecticut, was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance.